Norway Biobank Market Size & Outlook, 2026-2033
Global Market
Related Markets
Norway biobank market highlights
- The Norway biobank market generated a revenue of USD 456.6 million in 2025 and is expected to reach USD 694.5 million by 2033.
- The Norway market is expected to grow at a CAGR of 5.3% from 2026 to 2033.
- In terms of segment, services was the largest revenue generating product & services in 2025.
- Services is the most lucrative product & services segment registering the fastest growth during the forecast period.
Biobank market data book summary
| Market revenue in 2025 | USD 456.6 million |
| Market revenue in 2033 | USD 694.5 million |
| Growth rate | 5.3% (CAGR from 2026 to 2033) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, Norway accounted for 0.5% of the global biobank market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK biobank market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 15,714.9 million by 2033.
The Norway biobanks market is supported by the presence of large-scale national institutions and a rising demand for professional biobanks with standardized collection & handling procedures, and distinctive quality standards.
For instance, Biobank Norway, established in 2010, is the national biobank research entity in the country. The project is coordinated by the Norwegian University of Science and Technology and is funded by the Research Council of Norway Program for Research Infrastructures.
The project also encompasses population-based as well as disease-specific clinical biobanks in the country. Institutions such as these can strengthen competitive biobanking services for applications in clinical and epidemiological research, which can drive the country’s market.
No credit card required*
Publish Date: Dec 16, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biobank Market Scope
Biobank Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Tecan Group AG | View profile | 3,591 | Seestrasse 103, Mannedorf, Switzerland, 8708 | www.tecan.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | www.promocell.com/ |
| Taylor-Wharton | View profile | 251-500 | Baytown, Texas, United States, North America | twcryo.com |
Norway Biobank Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biobank Market Outlook will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 91.2% in 2025.
Horizon Databook has segmented the Norway biobank market based on product, services covering the revenue growth of each sub-segment from 2021 to 2033.
The Norway biobanks market is supported by the presence of large-scale national institutions and a rising demand for professional biobanks with standardized collection & handling procedures, and distinctive quality standards.
For instance, Biobank Norway, established in 2010, is the national biobank research entity in the country. The project is coordinated by the Norwegian University of Science and Technology and is funded by the Research Council of Norway Program for Research Infrastructures.
The project also encompasses population-based as well as disease-specific clinical biobanks in the country. Institutions such as these can strengthen competitive biobanking services for applications in clinical and epidemiological research, which can drive the country’s market.
- Norway Biobank Market Product & Services Outlook (Revenue, USD Million , 2021-2033)
- Product
- Services
- Norway Biobank Market Biospecimen Type Outlook (Revenue, USD Million , 2021-2033)
- Human Tissues
- Organs
- Stem Cells
- Other Biospecimens
- Norway Biobank Market Biobank Type Outlook (Revenue, USD Million , 2021-2033)
- Physical/Real Biobanks
- Virtual Biobanks
- Norway Biobank Market Application Outlook (Revenue, USD Million , 2021-2033)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
Reasons to subscribe to Biobank Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biobank Market Outlook databook
- Our clientele includes a mix of Biobank Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway Biobank Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Norway Biobank Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Norway Biobank Market, 2021-2033 (US$M)
Norway biobank market statistics, by product & services, 2021-2033 (US$M)
